Your browser doesn't support javascript.
loading
Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN.
Ma, Qinsiyu; Liu, Zhan'ao; Wang, Tengyu; Zhao, Pengfei; Liu, Mingrui; Wang, Yifang; Zhao, Weitong; Yuan, Ying; Li, Shuo.
Afiliação
  • Ma Q; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang 110122, China.
  • Liu Z; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang 110122, China.
  • Wang T; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang 110122, China.
  • Zhao P; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang 110122, China.
  • Liu M; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang 110122, China.
  • Wang Y; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang 110122, China.
  • Zhao W; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang 110122, China.
  • Yuan Y; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang 110122, China.
  • Li S; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang 110122, China.
Int J Mol Sci ; 24(22)2023 Nov 19.
Article em En | MEDLINE | ID: mdl-38003694

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Paclitaxel Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Paclitaxel Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article